Skip to content
10-Q

Quarterly Report

Inari Medical, Inc.

0001531048-24-000051

← back to feed
Filed
Jul 30, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Jul 26, 2024 58.27M sh
Shares Diluted Q2 2024 · Jun 30, 2024 58.14M sh
Shares Diluted Q2 2024 · Jun 30, 2024 58.04M sh
Shares Diluted Q2 2024 · Jun 30, 2023 58.5M sh
Shares Diluted Q2 2024 · Jun 30, 2023 55.99M sh
Capex Q2 2024 · Jun 30, 2024 $5.01M
Capex Q2 2024 · Jun 30, 2023 $2.19M
Operating Cash Flow Q2 2024 · Jun 30, 2024 −$775K
Operating Cash Flow Q2 2024 · Jun 30, 2023 $7.75M
Cash And Equivalents Q2 2024 · Jun 30, 2024 $70.13M
Cash And Equivalents Q2 2024 · Dec 31, 2023 $38.6M
Cash And Equivalents Q2 2024 · Jun 30, 2023 $57.84M
Stockholders Equity Q2 2024 · Jun 30, 2024 $423.81M
Stockholders Equity Q2 2024 · Mar 31, 2024 $447.23M
Stockholders Equity Q2 2024 · Dec 31, 2023 $464.91M
Stockholders Equity Q2 2024 · Jun 30, 2023 $435.65M
Stockholders Equity Q2 2024 · Mar 31, 2023 $426.74M
Stockholders Equity Q2 2024 · Dec 31, 2022 $417M
Current Liabilities Q2 2024 · Jun 30, 2024 $138.26M
Current Liabilities Q2 2024 · Dec 31, 2023 $76.34M
Total Liabilities Q2 2024 · Jun 30, 2024 $249.12M
Total Liabilities Q2 2024 · Dec 31, 2023 $209.33M
Current Assets Q2 2024 · Jun 30, 2024 $249.35M
Current Assets Q2 2024 · Dec 31, 2023 $235.56M
Total Assets Q2 2024 · Jun 30, 2024 $672.93M
Total Assets Q2 2024 · Dec 31, 2023 $674.24M
Eps Diluted Q2 2024 · Jun 30, 2024 −$0.54
Eps Diluted Q2 2024 · Jun 30, 2024 −$0.96
Eps Diluted Q2 2024 · Jun 30, 2023 $0.04
Eps Diluted Q2 2024 · Jun 30, 2023 $0.00
Eps Basic Q2 2024 · Jun 30, 2024 −$0.54
Eps Basic Q2 2024 · Jun 30, 2024 −$0.96
Eps Basic Q2 2024 · Jun 30, 2023 $0.04
Eps Basic Q2 2024 · Jun 30, 2023 $0.00
Sga Expense Q2 2024 · Jun 30, 2024 $114.15M
Sga Expense Q2 2024 · Jun 30, 2024 $217.21M
Sga Expense Q2 2024 · Jun 30, 2023 $85.59M
Sga Expense Q2 2024 · Jun 30, 2023 $171.29M
Rd Expense Q2 2024 · Jun 30, 2024 $24.91M
Rd Expense Q2 2024 · Jun 30, 2024 $51.79M
Rd Expense Q2 2024 · Jun 30, 2023 $21.09M
Rd Expense Q2 2024 · Jun 30, 2023 $43.15M
Net Income Q2 2024 · Jun 30, 2024 −$31.35M
Net Income Q2 2024 · Jun 30, 2024 −$55.55M
Net Income Q2 2024 · Mar 31, 2024 −$24.2M
Net Income Q2 2024 · Jun 30, 2023 $2.09M
Net Income Q2 2024 · Jun 30, 2023 −$133K
Net Income Q2 2024 · Mar 31, 2023 −$2.22M
Operating Income Q2 2024 · Jun 30, 2024 −$22.44M
Operating Income Q2 2024 · Jun 30, 2024 −$39.62M
Operating Income Q2 2024 · Jun 30, 2023 −$1.51M
Operating Income Q2 2024 · Jun 30, 2023 −$6.85M
Gross Profit Q2 2024 · Jun 30, 2024 $125.83M
Gross Profit Q2 2024 · Jun 30, 2024 $250.13M
Gross Profit Q2 2024 · Jun 30, 2023 $105.16M
Gross Profit Q2 2024 · Jun 30, 2023 $207.59M
Cost Of Revenue Q2 2024 · Jun 30, 2024 $19.99M
Cost Of Revenue Q2 2024 · Jun 30, 2024 $38.89M
Cost Of Revenue Q2 2024 · Jun 30, 2023 $13.84M
Cost Of Revenue Q2 2024 · Jun 30, 2023 $27.59M
Revenue Q2 2024 · Jun 30, 2024 $145.82M
Revenue Q2 2024 · Jun 30, 2024 $289.01M
Revenue Q2 2024 · Jun 30, 2023 $119.01M
Revenue Q2 2024 · Jun 30, 2023 $235.17M